 | • レポートコード：QYR9N8024 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、性索性腺間質腫瘍のグローバル市場について調査・分析したレポートで、種類別（診断、治療）、用途別（病院での使用、診療所での使用、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・性索性腺間質腫瘍の世界市場規模 ・主要企業別市場シェア ・性索性腺間質腫瘍の世界市場規模：種類別（診断、治療） ・性索性腺間質腫瘍の世界市場規模：用途別（病院での使用、診療所での使用、研究センター、その他） ・性索性腺間質腫瘍のアメリカ市場規模（種類別、用途別） ・性索性腺間質腫瘍のヨーロッパ市場規模（種類別、用途別） ・性索性腺間質腫瘍の中国市場規模（種類別、用途別） ・性索性腺間質腫瘍の日本市場規模（種類別、用途別） ・性索性腺間質腫瘍の東南アジア市場規模（種類別、用途別） ・性索性腺間質腫瘍のインド市場規模（種類別、用途別） ・性索性腺間質腫瘍の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・性索性腺間質腫瘍の世界市場予測（2019年-2025年） ・性索性腺間質腫瘍の地域別市場予測（2019年-2025年） ... |
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, Leydig cell tumor, gynandroblastoma, Sex Cord Tumor with Annular Tubules (SCTAT), and Sertoli Leydig cell tumor. In humans, this type of tumor accounts for 8% of the ovarian cancers and around 5% of testicular cancers.The Americas dominates the sex cord-gonadal stromal tumor market owing to the increasing prevalence of ovarian cancer in this region and high healthcare expenditure.
Europe holds the second position in the sex cord-gonadal stromal tumor market. The financial support provided by the government towards R & D and technological advancements are expected to drive the European sex cord-gonadal stromal tumor market. The increasing healthcare expenditure is also boosting the European sex cord-gonadal stromal tumor market.
In 2018, the global Sex Cord Gonadal Stromal Tumor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Sex Cord Gonadal Stromal Tumor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sex Cord Gonadal Stromal Tumor development in United States, Europe and China.
The key players covered in this study
Abbott, Abcam plc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Beckman Dickinson and Company
Bio SB Inc.
BioCurex
BioModa, Inc.
Bio-Rad Laboratories, Inc.
Boston Scientific Corporation
Cell Signaling Technology, Inc.
Clarient, Inc.
CooperSurgical Inc.
Correlogic Systems, Inc.
Danaher Corporation
Epigenomics AG
Market segment by Type, the product can be split into
Diagnosis
Treatment
Market segment by Application, split into
Hospital Use
Clinic Use
Research Center
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sex Cord Gonadal Stromal Tumor status, future forecast, growth opportunity, key market and key players.
To present the Sex Cord Gonadal Stromal Tumor development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Sex Cord Gonadal Stromal Tumor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type (2014-2025)
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2025)
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Research Center
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sex Cord Gonadal Stromal Tumor Market Size
2.2 Sex Cord Gonadal Stromal Tumor Growth Trends by Regions
2.2.1 Sex Cord Gonadal Stromal Tumor Market Size by Regions (2014-2025)
2.2.2 Sex Cord Gonadal Stromal Tumor Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sex Cord Gonadal Stromal Tumor Market Size by Manufacturers
3.1.1 Global Sex Cord Gonadal Stromal Tumor Revenue by Manufacturers (2014-2019)
3.1.2 Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sex Cord Gonadal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.2 Sex Cord Gonadal Stromal Tumor Key Players Head office and Area Served
3.3 Key Players Sex Cord Gonadal Stromal Tumor Product/Solution/Service
3.4 Date of Enter into Sex Cord Gonadal Stromal Tumor Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019)
4.2 Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019)
5 United States
5.1 United States Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
5.2 Sex Cord Gonadal Stromal Tumor Key Players in United States
5.3 United States Sex Cord Gonadal Stromal Tumor Market Size by Type
5.4 United States Sex Cord Gonadal Stromal Tumor Market Size by Application
6 Europe
6.1 Europe Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
6.2 Sex Cord Gonadal Stromal Tumor Key Players in Europe
6.3 Europe Sex Cord Gonadal Stromal Tumor Market Size by Type
6.4 Europe Sex Cord Gonadal Stromal Tumor Market Size by Application
7 China
7.1 China Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
7.2 Sex Cord Gonadal Stromal Tumor Key Players in China
7.3 China Sex Cord Gonadal Stromal Tumor Market Size by Type
7.4 China Sex Cord Gonadal Stromal Tumor Market Size by Application
8 Japan
8.1 Japan Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
8.2 Sex Cord Gonadal Stromal Tumor Key Players in Japan
8.3 Japan Sex Cord Gonadal Stromal Tumor Market Size by Type
8.4 Japan Sex Cord Gonadal Stromal Tumor Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
9.2 Sex Cord Gonadal Stromal Tumor Key Players in Southeast Asia
9.3 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Type
9.4 Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Application
10 India
10.1 India Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
10.2 Sex Cord Gonadal Stromal Tumor Key Players in India
10.3 India Sex Cord Gonadal Stromal Tumor Market Size by Type
10.4 India Sex Cord Gonadal Stromal Tumor Market Size by Application
11 Central & South America
11.1 Central & South America Sex Cord Gonadal Stromal Tumor Market Size (2014-2019)
11.2 Sex Cord Gonadal Stromal Tumor Key Players in Central & South America
11.3 Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Type
11.4 Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Application
12 International Players Profiles
12.1 Abbott, Abcam plc.
12.1.1 Abbott, Abcam plc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sex Cord Gonadal Stromal Tumor Introduction
12.1.4 Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.1.5 Abbott, Abcam plc. Recent Development
12.2 Affymetrix, Inc.
12.2.1 Affymetrix, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sex Cord Gonadal Stromal Tumor Introduction
12.2.4 Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.2.5 Affymetrix, Inc. Recent Development
12.3 Agilent Technologies, Inc.
12.3.1 Agilent Technologies, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sex Cord Gonadal Stromal Tumor Introduction
12.3.4 Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.3.5 Agilent Technologies, Inc. Recent Development
12.4 Beckman Dickinson and Company
12.4.1 Beckman Dickinson and Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sex Cord Gonadal Stromal Tumor Introduction
12.4.4 Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.4.5 Beckman Dickinson and Company Recent Development
12.5 Bio SB Inc.
12.5.1 Bio SB Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sex Cord Gonadal Stromal Tumor Introduction
12.5.4 Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.5.5 Bio SB Inc. Recent Development
12.6 BioCurex
12.6.1 BioCurex Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sex Cord Gonadal Stromal Tumor Introduction
12.6.4 BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.6.5 BioCurex Recent Development
12.7 BioModa, Inc.
12.7.1 BioModa, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sex Cord Gonadal Stromal Tumor Introduction
12.7.4 BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.7.5 BioModa, Inc. Recent Development
12.8 Bio-Rad Laboratories, Inc.
12.8.1 Bio-Rad Laboratories, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sex Cord Gonadal Stromal Tumor Introduction
12.8.4 Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.8.5 Bio-Rad Laboratories, Inc. Recent Development
12.9 Boston Scientific Corporation
12.9.1 Boston Scientific Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sex Cord Gonadal Stromal Tumor Introduction
12.9.4 Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.9.5 Boston Scientific Corporation Recent Development
12.10 Cell Signaling Technology, Inc.
12.10.1 Cell Signaling Technology, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sex Cord Gonadal Stromal Tumor Introduction
12.10.4 Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
12.10.5 Cell Signaling Technology, Inc. Recent Development
12.11 Clarient, Inc.
12.12 CooperSurgical Inc.
12.13 Correlogic Systems, Inc.
12.14 Danaher Corporation
12.15 Epigenomics AG
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Sex Cord Gonadal Stromal Tumor Key Market Segments
Table Key Players Sex Cord Gonadal Stromal Tumor Covered
Table Global Sex Cord Gonadal Stromal Tumor Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size Market Share by Type 2014-2025
Figure Diagnosis Figures
Table Key Players of Diagnosis
Figure Treatment Figures
Table Key Players of Treatment
Table Global Sex Cord Gonadal Stromal Tumor Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Use Case Studies
Figure Clinic Use Case Studies
Figure Research Center Case Studies
Figure Other Case Studies
Figure Sex Cord Gonadal Stromal Tumor Report Years Considered
Table Global Sex Cord Gonadal Stromal Tumor Market Size 2014-2025 (Million US$)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Regions 2014-2025 (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Regions 2014-2019 (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Share by Regions 2014-2019
Figure Global Sex Cord Gonadal Stromal Tumor Market Share by Regions 2014-2019
Figure Global Sex Cord Gonadal Stromal Tumor Market Share by Regions 2019
Table Market Top Trends
Table Global Sex Cord Gonadal Stromal Tumor Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Share by Manufacturers (2014-2019)
Figure Global Sex Cord Gonadal Stromal Tumor Market Share by Manufacturers in 2018
Table Global Sex Cord Gonadal Stromal Tumor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sex Cord Gonadal Stromal Tumor Product/Solution/Service
Table Date of Enter into Sex Cord Gonadal Stromal Tumor Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Size Share by Type (2014-2019)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size Market Share by Type (2014-2019)
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table Global Sex Cord Gonadal Stromal Tumor Market Size Share by Application (2014-2019)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size Market Share by Application (2014-2019)
Figure Global Sex Cord Gonadal Stromal Tumor Revenue Market Share by Application in 2018
Figure United States Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table United States Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table United States Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table United States Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table United States Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table United States Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table United States Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure Europe Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table Europe Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table Europe Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table Europe Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table Europe Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table Europe Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table Europe Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure China Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table China Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table China Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table China Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-20189) (Million US$)
Table China Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table China Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table China Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure Japan Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table Japan Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table Japan Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table Japan Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table Japan Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table Japan Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table Japan Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure India Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table India Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table India Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table India Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table India Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table India Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table India Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Figure Central & South America Sex Cord Gonadal Stromal Tumor Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sex Cord Gonadal Stromal Tumor Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sex Cord Gonadal Stromal Tumor Market Share (2018-2019)
Table Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sex Cord Gonadal Stromal Tumor Market Share by Type (2014-2019)
Table Central & South America Sex Cord Gonadal Stromal Tumor Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sex Cord Gonadal Stromal Tumor Market Share by Application (2014-2019)
Table Abbott, Abcam plc. Company Details
Table Abbott, Abcam plc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019) (Million US$)
Figure Abbott, Abcam plc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Abbott, Abcam plc. Recent Development
Table Affymetrix, Inc. Company Details
Table Affymetrix, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Affymetrix, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Affymetrix, Inc. Recent Development
Table Agilent Technologies, Inc. Company Details
Table Agilent Technologies, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Agilent Technologies, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Agilent Technologies, Inc. Recent Development
Table Beckman Dickinson and Company Company Details
Table Beckman Dickinson and Company Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Beckman Dickinson and Company Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Beckman Dickinson and Company Recent Development
Table Bio SB Inc. Company Details
Table Bio SB Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Bio SB Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Bio SB Inc. Recent Development
Table BioCurex Company Details
Table BioCurex Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure BioCurex Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table BioCurex Recent Development
Table BioModa, Inc. Company Details
Table BioModa, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure BioModa, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table BioModa, Inc. Recent Development
Table Bio-Rad Laboratories, Inc. Company Details
Table Bio-Rad Laboratories, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Bio-Rad Laboratories, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Bio-Rad Laboratories, Inc. Recent Development
Table Boston Scientific Corporation Company Details
Table Boston Scientific Corporation Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Boston Scientific Corporation Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Boston Scientific Corporation Recent Development
Table Cell Signaling Technology, Inc. Company Details
Table Cell Signaling Technology, Inc. Revenue in Sex Cord Gonadal Stromal Tumor Business (2014-2019)(Million US$)
Figure Cell Signaling Technology, Inc. Revenue Growth Rate in Sex Cord Gonadal Stromal Tumor Business (2014-2019)
Table Cell Signaling Technology, Inc. Recent Development
Table Clarient, Inc. Company Details
Table CooperSurgical Inc. Company Details
Table Correlogic Systems, Inc. Company Details
Table Danaher Corporation Company Details
Table Epigenomics AG Company Details
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Regions (Million US$) 2019-2025
Figure Global Sex Cord Gonadal Stromal Tumor Market Size Share by Regions (2019-2025)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size Share by Regions in 2025
Figure United States Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure China Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure India Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sex Cord Gonadal Stromal Tumor Market Size Forecast (2019-2025)(Million USD)
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Product (2019-2025) (Million US$)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size by Product (2019-2025)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size by Product in 2025
Table Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2019-2025) (Million US$)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size by Application (2019-2025)
Figure Global Sex Cord Gonadal Stromal Tumor Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の性腺生殖腺間質腫瘍の治療市場：市場規模・現状・予測 The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. In 2018, the global Sex Cord Gonadal Stromal Tumor Treatment market size was xx million US$ and it is expected to reac…- 世界の腫瘍治療フィールド（TTFields）市場：市場規模・現状・予測 Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer.North America is projected to hold largest…
- 世界の転移性脊髄腫瘍市場：市場規模・現状・予測 A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the …
- 世界のウィルムス腫瘍治療市場2019 The global Wilms' Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Wilms' Tumor Treatment market status and forecast, categorizes the global Wilms' Tumor Treatment market size…
- 世界の間質細胞由来因子1市場2019 The global Stromal Cell Derived Factor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Stromal Cell Derived Factor 1 market status and forecast, categorizes the global Stromal Cell Derived…